Genetic reconstitution of tumorigenesis in primary intestinal cells
暂无分享,去创建一个
T. Imai | H. Nakagama | Y. Hippo | Mami Takahashi | M. Ochiai | K. Onuma | Kaoru Orihashi
[1] E. Lander,et al. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Nakagama,et al. Modeling human colon cancer in rodents using a food‐borne carcinogen, PhIP , 2005, Cancer science.
[3] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[4] Bruce J. Aronow,et al. The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor , 2012, Cell.
[5] J. Epstein,et al. Interconversion Between Intestinal Stem Cell Populations in Distinct Niches , 2011, Science.
[6] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[7] M. Capecchi,et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations , 2011, Proceedings of the National Academy of Sciences.
[8] Clarke Ar,et al. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. , 1995 .
[9] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[10] Ian P Newton,et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. , 2004, Genes & development.
[11] M. Washington,et al. Epithelial Tissues Have Varying Degrees of Susceptibility to KrasG12D-Initiated Tumorigenesis in a Mouse Model , 2011, PloS one.
[12] E. Fuchs,et al. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos , 2010, Nature Medicine.
[13] Umar Mahmood,et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.
[14] H. Clevers,et al. Controlled gene expression in primary Lgr5 organoid cultures , 2011, Nature Methods.
[15] Erika Pastrana,et al. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.
[16] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[17] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[18] R. Richardson,et al. Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.
[19] J. Gore,et al. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer , 2012, Oncology reports.
[20] Takuji Tanaka. Colorectal carcinogenesis: Review of human and experimental animal studies , 2009, Journal of carcinogenesis.
[21] Julie A. Wilkins,et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo , 2006, Proceedings of the National Academy of Sciences.
[22] Kristian Cibulskis,et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.
[23] H. Esumi,et al. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. , 1995, Gastroenterology.
[24] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[25] M. Kay Washington,et al. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] Jayadev Raju. Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. , 2008, World journal of gastroenterology.
[27] R. Medzhitov,et al. Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.
[28] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[29] Charles Swanton,et al. Genetic prognostic and predictive markers in colorectal cancer , 2009, Nature Reviews Cancer.
[30] Camilla A. Richmond,et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells , 2010, Proceedings of the National Academy of Sciences.
[31] T. Sugimura,et al. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. , 2000, Carcinogenesis.
[32] Miguel Abal,et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. , 2006, Gastroenterology.
[33] Takuji Tanaka,et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms , 2006, International journal of cancer.
[34] M. Taketo,et al. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.
[35] A. Sweet-Cordero,et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.
[36] Y. Asmann,et al. A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.
[37] Hans Clevers,et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.
[38] T. Noda,et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. , 1997, Science.
[39] L. Donehower,et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Fodde,et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. , 2002, Human molecular genetics.
[41] Andreas Trumpp,et al. Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation , 2008, Nature Genetics.
[42] H. Clevers,et al. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.
[43] E. Casanova,et al. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. , 2010, Gastroenterology.
[44] M. Taketo,et al. Mouse models of colon cancer. , 2009, Gastroenterology.
[45] Richard B Halberg,et al. The Pleiotropic Phenotype of Apc Mutations in the Mouse: Allele Specificity and Effects of the Genetic Background , 2008, Genetics.
[46] T. Sugimura,et al. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. , 2007, Cancer research.
[47] M. Bertagnolli,et al. Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.
[48] L. Naldini,et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[49] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[50] Choun-Ki Joo,et al. Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.
[51] Fa-An Chao,et al. Structure and dynamics of a primordial catalytic fold generated by in vitro evolution , 2012, Nature chemical biology.
[52] M. Cummings,et al. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. , 1995, Oncogene.
[53] Kathleen R. Cho,et al. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. , 2011, Gastroenterology.
[54] M. Washington,et al. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin. , 2007, Carcinogenesis.